Skip to content

Medtronic MDT Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies

Artivion logo
ArtivionAORT
-$10.5M-189%
CONMED logo
CONMEDCNMD
$11.57M+302%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$7.73M+126%
Intuitive Surgical logo
Intuitive SurgicalISRG
-$26.6M-110%
Insulet logo
InsuletPODD
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$111.21B-6.1%
Enterprise value$138.47B-5.1%
P/E23.2×-2.2×
P/S3.1×-0.5×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's cash provided by (used in) investing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's cash provided by (used in) investing activity, including discontinued operation?
Medtronic (MDT) reported cash provided by (used in) investing activity, including discontinued operation of -$917M in Q1 2026.
How has Medtronic's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
Medtronic's cash provided by (used in) investing activity, including discontinued operation decreased by 87.1% year-over-year, from -$490M to -$917M.
What is the long-term trend for Medtronic's cash provided by (used in) investing activity, including discontinued operation?
Over 3 years (2023 to 2026), Medtronic's cash provided by (used in) investing activity, including discontinued operation has grown at a -5.6% compound annual growth rate (CAGR), from -$3.49B to -$2.93B.
What does cash provided by (used in) investing activity, including discontinued operation mean?
The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.